BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25696895)

  • 1. Replacing bad (F)actors: hemophilia.
    Doering CB; Spencer HT
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):461-7. PubMed ID: 25696895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in gene therapy for hemophilia.
    Chuah MK; Nair N; VandenDriessche T
    Hum Gene Ther; 2012 Jun; 23(6):557-65. PubMed ID: 22671033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative strategies for gene therapy of hemophilia.
    Montgomery RR; Shi Q
    Hematology Am Soc Hematol Educ Program; 2010; 2010():197-202. PubMed ID: 21239794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional aspects of factor VIII expression after transplantation of genetically-modified hematopoietic stem cells for hemophilia A.
    Ide LM; Iwakoshi NN; Gangadharan B; Jobe S; Moot R; McCarty D; Doering CB; Spencer HT
    J Gene Med; 2010 Apr; 12(4):333-44. PubMed ID: 20209485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells.
    Doering CB; Archer D; Spencer HT
    Adv Drug Deliv Rev; 2010 Sep; 62(12):1204-12. PubMed ID: 20869414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for hemophilia.
    Chuah MK; Collen D; VandenDriessche T
    J Gene Med; 2001; 3(1):3-20. PubMed ID: 11269333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and challenges in the development of a cell-based therapy for hemophilia A.
    Fomin ME; Togarrati PP; Muench MO
    J Thromb Haemost; 2014 Dec; 12(12):1954-65. PubMed ID: 25297648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lasting power of new clotting proteins.
    Powell JS
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):355-63. PubMed ID: 25696879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy strategies for hemophilia: benefits versus risks.
    Petrus I; Chuah M; VandenDriessche T
    J Gene Med; 2010 Oct; 12(10):797-809. PubMed ID: 20848668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetics of hemophilia A].
    De Brasi CD; Slavutsky IR; Larripa IB
    Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for hemophilia: clinical trials and technical tribulations.
    Viiala NO; Larsen SR; Rasko JE
    Semin Thromb Hemost; 2009 Feb; 35(1):81-92. PubMed ID: 19308896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onco-retroviral and lentiviral vector-based gene therapy for hemophilia: preclinical studies.
    Van Damme A; Chuah MK; Collen D; VandenDriessche T
    Semin Thromb Hemost; 2004 Apr; 30(2):185-95. PubMed ID: 15118930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB
    Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
    Margaritis P; Arruda VR; Aljamali M; Camire RM; Schlachterman A; High KA
    J Clin Invest; 2004 Apr; 113(7):1025-31. PubMed ID: 15057309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances toward gene therapy for hemophilia at the millennium.
    Kaufman RJ
    Hum Gene Ther; 1999 Sep; 10(13):2091-107. PubMed ID: 10498242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene transfer as an approach to treating hemophilia.
    High KA
    Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic correction and stable expression of factor VIII in hemophilia A mice by embryonic stem cell therapy.
    Wang JJ; Kuang Y; Zhang LL; Shen CL; Wang L; Lu SY; Lu XB; Fei J; Gu MM; Wang ZG
    Genet Mol Res; 2013 May; 12(2):1511-21. PubMed ID: 23765957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy, bioengineered clotting factors and novel technologies for hemophilia treatment.
    Pierce GF; Lillicrap D; Pipe SW; Vandendriessche T
    J Thromb Haemost; 2007 May; 5(5):901-6. PubMed ID: 17459005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New high-technology products for the treatment of haemophilia.
    Pipe SW; Saint-Remy JM; Walsh CE
    Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.